BSACI guideline for the management of chronic urticaria and angioedema
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2015/02/25
-
Journal
-
Indian UGC (journal)
-
Refrences155
-
Citations128
-
R. J. Powell Department of Clinical Immunology and Allergy Nottingham University Nottingham UK
-
S. C. Leech Department of Child Health Kings College Hospital London UK
-
S. Till Division of Asthma, Allergy and Lung Biology Kings College London London UK
-
P. A. J. Huber BSACI British Society for Allergy & Clinical Immunology London UK ORCID (unauthenticated)
-
S. M. Nasser Department of Allergy & Clinical Immunology Addenbrooke's NHS Trust Cambridge UK
-
A. T. Clark Department of Allergy Addenbrookes NHS Trust Cambridge UK
Abstract
Cite
Powell, R. J., et al. “BSACI Guideline for the Management of Chronic Urticaria and Angioedema”. Clinical &Amp; Experimental Allergy, vol. 45, no. 3, 2015, pp. 547-65, https://doi.org/10.1111/cea.12494.
Powell, R. J., Leech, S. C., Till, S., Huber, P. A. J., Nasser, S. M., & Clark, A. T. (2015). BSACI guideline for the management of chronic urticaria and angioedema. Clinical &Amp; Experimental Allergy, 45(3), 547-565. https://doi.org/10.1111/cea.12494
Powell RJ, Leech SC, Till S, Huber PAJ, Nasser SM, Clark AT. BSACI guideline for the management of chronic urticaria and angioedema. Clinical & Experimental Allergy. 2015;45(3):547-65.
Journal Categories
Medicine
Internal medicine
Infectious and parasitic diseases
Medicine
Internal medicine
Specialties of internal medicine
Immunologic diseases
Allergy
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| First-Trimester Drug Use and Congenital Disorders | JAMA |
| 88 | 1981 |
Tranexamic acid (Cyklokapron) in chronic urticaria: a double-blind study | Acta Dermato-Venereologica |
| 28 | 1977 |
| British guideline on the management of asthma | Thorax |
| 2003 | |
| Histamine H2‐receptor antagonists for urticaria | 2012 | |||
| Comparative effects of fexofenadine and montelukast on allergen‐induced wheal and flare | 2005 |
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| A practical approach to the diagnosis and management of chronic urticaria | Paediatrics and Child Health | 2024 | ||
A Survey of Treatment Practices in Management of Chronic Urticaria Patients among Dermatologists of India | Clinical Dermatology Review |
| 2024 | |
Impact of Omalizumab Treatment on Quality of Life and Activity of Chronic Spontaneous Urticaria | Eurasian Journal of Critical Care | 2024 | ||
| A Patient Charter for Chronic Urticaria | Advances in Therapy |
| 2023 | |
| Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status | Dermatology and Therapy |
| 1 | 2023 |
Citations Analysis
The category
Medicine: Medicine (General) 46
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Corticosteroid Therapy for Children in Pediatric Emergency Department and was published in 2015. The most recent citation comes from a 2024 study titled Impact of Omalizumab Treatment on Quality of Life and Activity of Chronic Spontaneous Urticaria. This article reached its peak citation in 2021, with 21 citations. It has been cited in 82 different journals, 31% of which are open access. Among related journals, the Clinical & Experimental Allergy cited this research the most, with 6 citations. The chart below illustrates the annual citation trends for this article.